Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and endoxan: a prospective randomized controlled clinical trial

Autor: Xu, Yinggang1 (AUTHOR), Huang, Lifeng2 (AUTHOR), Wang, Jue2,3 (AUTHOR), He, Jinzhi2 (AUTHOR), Wang, Ye2 (AUTHOR), Zhang, Weiwei2 (AUTHOR), Chen, Rui2 (AUTHOR), Huang, Xiaofeng2 (AUTHOR), Liu, Jin4 (AUTHOR), Wan, Xinyu2 (AUTHOR), Shi, Wenjie2 (AUTHOR), Xu, Lu5 (AUTHOR) lulu-x-u@163.com, Zha, Xiaoming2,3 (AUTHOR) njzhaxm@njmu.edu.cn
Zdroj: BMC Cancer. 11/12/2024, Vol. 24 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje